Sammanfattning
Access to second-line antiretroviral therapy (ART) for HIV-positive patients remains limited in sub-Saharan Africa. Furthermore, outcomes of second-line ART may be compromised by mortality and loss to follow-up (LTFU).
Originalspråk | engelska |
---|---|
Artikelnummer | 29943 |
Tidskrift | Global Health Action |
Volym | 9 |
DOI | |
Status | Published - 2016 jan. 12 |
Ämnesklassifikation (UKÄ)
- Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi